Jump Financial’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$237K Buy
+38,400
New +$211K ﹤0.01% 1775
2026
Q1
Sell
-75,940
Closed -$400K 1822
2025
Q4
$400K Buy
+75,940
New +$382K ﹤0.01% 1415
2024
Q2
Sell
-25,440
Closed -$184K 1745
2024
Q1
$184K Sell
25,440
-14,317
-36% -$90.7K 0.01% 1701
2023
Q4
$199K Buy
+39,757
New +$175K 0.01% 1568

Other funds holding ABEO

Jump Financial's ABEO Position: Q2 2026 in Review

Jump Financial opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 38,400 shares worth $237K. The stake represents ﹤0.01% of the portfolio and ranks #1775 among its holdings. This is a return to the name: Jump Financial previously reported a position in ABEO as recently as Q4 2025.

Jump Financial first reported a position in ABEO in Q4 2023 and has held it in 4 quarters since. The position peaked at $400K in Q4 2025. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Jump Financial held 38,400 shares of Abeona Therapeutics worth $237K as of Q2 2026.
  • Abeona Therapeutics was a new Jump Financial position in Q2 2026.
  • Abeona Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1775 holding.
  • Jump Financial first reported a position in Abeona Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • Jump Financial's Abeona Therapeutics position peaked at $400K in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.